J Korean Orthop Res Soc.  2013 Dec;16(2):40-47.

Comparison of Clinicopathologic and Immunohistochemical Features between Localized and Diffuse Types of Tenosynovial Giant Cell Tumor

Affiliations
  • 1Department of Orthopaedic Surgery, Pusan National University School of Medicine, Yangsan, Korea.
  • 2Department of Pathology, Pusan National University School of Medicine, Yangsan, Korea. cnlee@pusan.ac.kr

Abstract

PURPOSE
Tenosynovial giant cell tumors (TSGCT) can be classified into localized and diffuse types. To identify reliable diagnostic markers for these tumors, we compared clinicopathologic and immunohistochemical features in localized and diffuse type TSGCT.
MATERIALS AND METHODS
Clinicopathologic and immunohistochemical studies were perfomed. Thirty cases which had been histologically diagnosed as TSGCT after surgery, at our hospital from 2000 to 2012, were analyzed.
RESULTS
There was no statistically significant difference between the groups for gender, age, site, recurrence, symptom (p>0.05). Macrophage colony-stimulating factor (MCSF), CD68, and Ki67 expression was identified in localized and diffuse type TSGCT. But there was no statistically significant difference between the groups for MCSF, CD68, and Ki67 expression (p>0.05).
CONCLUSION
This study shows that although the markers MCSF, CD68, and Ki67 are expressed by localized and diffuse type TSGCT, their lack of specificity limits their use as a subsidiary immunohistochemical marker in the differential diagnosis of localized and diffuse type TSGCTs.

Keyword

Tenosynovial giant cell tumor; Immunohistochemical study; MCSF

MeSH Terms

Diagnosis, Differential
Giant Cell Tumors*
Giant Cells*
Macrophage Colony-Stimulating Factor
Recurrence
Sensitivity and Specificity
Macrophage Colony-Stimulating Factor
Full Text Links
  • JKORS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr